I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 26 studies | 45% ± 16% | |
| natural killer cell | 21 studies | 20% ± 6% | |
| CD8-positive, alpha-beta T cell | 18 studies | 25% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 23% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 8 studies | 27% ± 10% | |
| gamma-delta T cell | 8 studies | 31% ± 14% | |
| CD8-positive, alpha-beta memory T cell | 7 studies | 27% ± 7% | |
| mature NK T cell | 7 studies | 20% ± 3% | |
| T follicular helper cell | 7 studies | 41% ± 18% | |
| T cell | 6 studies | 27% ± 12% | |
| effector CD8-positive, alpha-beta T cell | 6 studies | 30% ± 16% | |
| exhausted T cell | 4 studies | 43% ± 15% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 27% ± 4% | |
| effector CD4-positive, alpha-beta T cell | 3 studies | 21% ± 5% |
